Ticker Symbol: BLTE
Belite Bio Inc - ADR
Exchange: NASDAQ
Currency:
USD
Asset
Type: ADR
CIK:0001889109
Company Profile
belite bio inc is a san diego based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. developed from our anti-rbp4 technology platform, our lead candidate, lbs-008, is currently in a phase i clinical trial for dry age-related macular degeneration and its juvenile form, stargardt disease. lbs-008 has received orphan drug status in the us and europe, as well as rare pediatric disease status in the us.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: N/A
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $34.24
Change:
$1.89
(
5.84%)
Days Range: $31.63 - $34.29
Beta: -0.06
52wk. High: $36.70
52wk. Low: $11.00
Ytd. Change 19.43%
50 Day Moving Average: $31.42
200 Day Moving Average: $24.59
Shares Outstanding: 27230000
Valuation
Market Cap: 93.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A